已收盘 07-02 16:00:00 美东时间
+0.250
+1.76%
今日重点评级关注:摩根大通:上调Camp4 Therapeutics评级至"超配",目标价从5美元升至9美元;Canaccord Genuity:维持Rhythm制药"买入"评级,目标价从143美元升至151美元
06-17 11:32
Ladenburg Thalmann analyst Floris Van Dijkum maintains Park Hotels & Resorts (NYSE:PK) with a Buy and raises the price target from $16 to $20.
06-17 00:56
多张Call单大涨超200%,Meta看涨期权占比75%;“大空头”再发警告,Palantir看跌期权占比提升;惊现远期看跌期权,押注华纳未来一年跌超25%>>
06-04 19:29
The 2026 FIFA World Cup could provide a temporary boost to a range of consumer, media, and gaming stocks, with hotels, restaurants, broadcasters, and sports-betting operators among the biggest potenti...
06-03 18:48
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从13.5美元升至14美元;BTIG:维持Jade Biosciences"买入"评级,目标价从39美元升至74美元
06-02 16:25
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
Truist Securities analyst Patrick Scholes maintains Park Hotels & Resorts (NYSE:PK) with a Hold and raises the price target from $12 to $13.
05-27 00:53
今日重点评级关注:瑞杰金融:上调InflaRx评级至"强烈买入",目标价从7美元升至9美元;巴克莱:维持Orchestra BioMed Hldgs"超配"评级,目标价从12美元升至13美元
05-14 14:32
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Morgan Stanley analyst Stephen Grambling maintains Park Hotels & Resorts (NYSE:PK) with a Equal-Weight and raises the price target from $10 to $10.5.
05-13 01:04